Low likelihood of tumour homologous recombination deficiency (HRD) in high-grade ovarian carcinomas (HGOCs) harbouring a germline BRIP1 or PALB2 pathogenic variant (PV)

  • K. Connors
  • , G. J. Burghel
  • , C. Ramsden
  • , Z. Salih
  • , C. Mitchell
  • , J. Hasan
  • , A. R. Clamp
  • , G. C. Jayson
  • , G. Evans
  • , S. Taylor
  • , R. D. Morgan

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages2
JournalAnnals of Oncology
Volume36
DOIs
Publication statusPublished - Sept 2025

Cite this